A phase 1 randomized, double-blind, placebo-controlled, crossover trial of DAS181 (Fludase®) in adult subjects with well-controlled asthma

Peer Review reports

Original Submission
21 Sep 2015	Submitted	Original manuscript
16 Oct 2015	Reviewed	Reviewer Report - Shetty Ravi Dyavar
20 Oct 2015	Reviewed	Reviewer Report - Huang Huang
8 Nov 2015	Author responded	Author comments - Rhonda Colombo
Resubmission - Version 2
8 Nov 2015	Submitted	Manuscript version 2
10 Nov 2015	Reviewed	Reviewer Report - Huang Huang
14 Nov 2015	Reviewed	Reviewer Report - Shetty Ravi Dyavar
10 Dec 2015	Author responded	Author comments - Rhonda Colombo
Resubmission - Version 3
10 Dec 2015	Submitted	Manuscript version 3
Publishing
18 Jan 2016	Editorially accepted
1 Feb 2016	Article published	10.1186/s12879-016-1358-9

Back to article page